Secondary haemochromatosis in a haemodialysis patient
Singapore medical journal
;
: e124-6, 2015.
Article
in English
| WPRIM
| ID: wpr-337116
ABSTRACT
A 39-year-old woman with end-stage renal disease, which was maintained on haemodialysis, developed secondary haemochromatosis after receiving blood transfusions and intravenous iron supplementation without sufficient serum ferritin concentration monitoring. The patient received intravenous deferoxamine three times a week, combined with high-dose recombinant human erythropoietin therapy and haemodialysis. After three months, improvements in biochemical indicators and iron overload were noted.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Therapeutics
/
Blood
/
Recombinant Proteins
/
Hemoglobins
/
Transferrin
/
Tomography, X-Ray Computed
/
Chelating Agents
/
Chemistry
/
Erythropoietin
/
Renal Dialysis
Limits:
Adult
/
Female
/
Humans
Language:
English
Journal:
Singapore medical journal
Year:
2015
Type:
Article
Similar
MEDLINE
...
LILACS
LIS